How to Develop a Copper Peptide Scalp Micro-Infusion System for Private Label

    Interest in advanced scalp care is moving beyond conventional dropper serums. Brands are increasingly exploring treatment systems that combine a concentrated scalp formula with a purpose-designed application device and a structured treatment protocol.  

    One concept receiving particular attention is the copper peptide scalp micro-infusion system: a premium kit built around a GHK-Cu or multi-peptide scalp serum, individual treatment doses or ampoules, a compatible scalp application device, replacement treatment heads and retail-ready private label packaging.  

    However, developing this type of product requires more planning than sourcing a standard cosmetic serum. Formula stability, packaging compatibility, device documentation, intended use, marketing claims and regulatory classification all need to be considered before commercial production begins.  

    1. Start With the Complete Treatment System, Not Only the Serum  

    A common mistake is to develop the serum first and source the application device later. A stronger OEM/ODM project begins by defining the entire commercial system.  

    Defining the architecture early helps the manufacturer evaluate MOQ, packaging dimensions, assembly requirements, compatibility testing and regulatory responsibilities before tooling or printed packaging is ordered.  

    2. Choosing the Copper Peptide Formula Direction  

    Copper peptides are commonly selected for premium scalp formulations because they allow brands to build a differentiated peptide-focused positioning while combining them with other scalp-conditioning ingredients.  

GHK-Cu-Focused Formula

    A simple development route is a lightweight leave-on serum built around GHK-Cu, supported by humectants and scalp-conditioning ingredients.  

    For premium positioning, the development objective should not simply be adding a long ingredient list. The manufacturer needs to consider peptide compatibility, appearance, pH, stability, viscosity, residue and packaging interaction.  

Multi-Active Scalp Formula

    Another direction combines copper peptide technology with selected supporting ingredients such as:  

   
• Niacinamide
   
• Caffeine
   
• Panthenol
   
• Betaine
   
• Zinc PCA
   
• Additional peptide complexes
   
• Selected botanical extracts
   
• Fermentation-derived ingredients
 

    The correct combination depends on the brand positioning, target texture, intended claims, target market and desired treatment experience.  

Existing Formula vs Custom Formula

    3. Ampoules, Single-Dose Vials and Refill Formats  

    Packaging format is particularly important in a micro-infusion concept because consumers may expect a controlled amount of serum for each treatment.  

    Possible formats include:  

   
• Small individual cosmetic ampoules
   
• Single-treatment vials
   
• Multi-use serum bottles
   
• Dropper bottles
   
• Airless dispensing systems
   
• Refill packs sold independently from the main device kit
 

    Brands considering approximately 5 ml single-dose formats should confirm filling feasibility, packaging availability and MOQ early in development.  

    4. The Device Must Be Evaluated as a Separate Development Workstream  

    The application device should not be treated as a simple packaging accessory.  

    The manufacturer and brand should first document:  

   
• The device's intended purpose
   
• How it interacts with the scalp
   
• How serum is introduced or dispensed
   
• Whether treatment heads are reusable or single use
   
• Materials contacting the product or skin
   
• Cleaning or replacement requirements
   
• Packaging and transport protection
   
• Device supplier documentation
   
• Target sales market
   
• Claims that will appear on packaging and advertising
 

    These factors can affect the technical and regulatory pathway of the finished product.  

    For this reason, a responsible OEM/ODM supplier should avoid selecting a device specification solely because a competing product uses it. The device should instead be assessed against the intended application, target market and applicable regulatory requirements.  

    5. Do Not Choose the Device Specification From Marketing Alone  

    Brands frequently ask an OEM supplier to recommend a specific microneedling specification immediately.  

    For a commercial private label project, that decision should come after the intended-use and regulatory review rather than before it.  

    The correct specification may depend on:  

   
• Whether the device is positioned as cosmetic or for a medical purpose
   
• Its physical mode of action
   
• Target treatment area
   
• Home-use positioning
   
• Product claims
   
• Applicable market regulations
   
• Risk-management requirements
 

    A qualified regulatory assessment should therefore be completed before finalising the device specification, instructions and claims.  

    6. Serum and Device Compatibility Needs to Be Checked Together  

    Even if the serum and device are independently acceptable, they still need to function as a commercial system.  

    During development, manufacturers may evaluate factors including:  

   
• Serum viscosity and flow behaviour
   
• Compatibility with the selected dispensing mechanism
   
• Potential blockage or inconsistent delivery
   
• Contact between serum and device materials
   
• Leakage during transport
   
• Packaging seal integrity
   
• Storage stability
   
• Ease of assembly
 

    This is why the final packaging and device should ideally be included in compatibility testing rather than evaluating the serum only in a laboratory sample bottle.  

    7. Testing and Technical Documentation  

    Documentation requirements vary according to the product, market and regulatory classification. A private label buyer should establish the documentation checklist before approving mass production.  

For the Serum

   
• Full INCI ingredient list
   
• Formula specification
   
• Certificate of Analysis where applicable
   
• SDS/MSDS where applicable
   
• Stability testing
   
• Microbiological testing
   
• Packaging compatibility evaluation
   
• Batch documentation and traceability
   
• Shelf-life information
   
• Active ingredient documentation where available
   
• Supporting documentation for safety assessment and Product Information File preparation
 

For the Device

   
• Device specifications
   
• Material information
   
• Manufacturer information
   
• Applicable conformity documentation
   
• Risk and technical documentation where required
   
• Instructions for use
   
• Batch or lot traceability where applicable
   
• Market-specific regulatory documentation
 

    8. UK and EU Regulatory Planning Should Start Before Packaging Design  

    For products intended for the UK or European market, regulatory planning should begin before the carton, leaflet and marketing claims are finalised.  

    The serum and the application device may follow different regulatory pathways. Whether a particular device is regulated as a medical device depends on factors including its intended purpose, design and claims, so classification should be confirmed for the actual final product rather than assumed from the appearance of similar products.  

    Brands should therefore review:  

   
• Cosmetic compliance requirements for the serum
   
• Product safety assessment requirements
   
• Responsible Person arrangements
   
• Product Information File requirements
   
• Device classification
   
• Applicable CE, UKCA or other conformity requirements
   
• Market registration requirements
   
• Labelling requirements
   
• Permitted product claims
 

    9. Peptide Identity and Raw-Material Documentation  

    A premium copper peptide project should also evaluate the documentation behind the active ingredient itself.  

    Depending on the ingredient supplier and project requirements, supporting information may include:  

   
• Raw-material specification
   
• Certificate of Analysis
   
• Ingredient identity documentation
   
• Purity or assay information where relevant
   
• Recommended storage conditions
   
• Raw-material lot traceability
 

    The objective is not simply to print “GHK-Cu” prominently on the carton. The formula and supporting documentation should be developed together from the beginning.  

    10. Premium Packaging Architecture  

    A micro-infusion system is typically positioned above a conventional scalp serum, so presentation has a major influence on perceived value.  

    A complete packaging structure may include:  

   
• Rigid or premium folding carton
   
• Internal tray to separate the device and serum
   
• Individual ampoule compartments
   
• Custom device colour where MOQ allows
   
• Logo printing or laser marking
   
• Custom ampoule or vial labels
   
• Instruction leaflet
   
• QR code for digital instructions or brand education
   
• Batch and traceability information
 

    Packaging design should begin only after the actual bottle, ampoule and device dimensions have been confirmed. Designing the retail box too early often creates unnecessary revisions.  

    11. Plan the Refill Business From the Beginning  

    One important commercial advantage of this category is the possibility of separating the initial kit from future consumable purchases.  

    Instead of treating the project as a single SKU, the brand can consider an architecture such as:  

    Planning this structure during OEM development helps keep refill packaging, filling volumes and future production MOQ commercially workable.  

    12. Sampling Should Compare Systems, Not Just Ingredients  

    For a new brand, it is often more useful to compare two or three carefully differentiated prototypes than to request many unrelated serum samples.  

    For example:  

    The brand can then evaluate sensory profile, residue, packaging compatibility and overall product positioning before moving into final formula confirmation.  

    13. A Practical OEM/ODM Development Process  

    14. Questions to Send Your Manufacturer  

    When sourcing a copper peptide scalp micro-infusion system, a useful RFQ should ask more than price.  

   
• Do you manufacture GHK-Cu or other peptide scalp serums?
   
• Can you provide existing formulas and custom development?
   
• What peptide documentation is available?
   
• Can the serum be filled into small single-dose formats?
   
• Is the format cosmetic single-dose or genuinely sterile?
   
• What device documentation is available?
   
• Can you coordinate the device, serum, packaging and assembly?
   
• Can serum and device compatibility be evaluated?
   
• What testing can be provided?
   
• What support is available for UK/EU documentation?
   
• What are the MOQs for standard and fully customised versions?
   
• Can refill serum be manufactured as a separate SKU?
 

    Developing a Scalable Scalp Treatment Platform  

    The strongest copper peptide micro-infusion projects are designed as product platforms rather than one-time kits.  

    A brand might begin with a premium hero system and later expand into complementary formats such as a daily scalp serum, lightweight scalp mist, peptide tonic, treatment oil or refill programme.  

    This approach allows formulation, packaging and supplier relationships developed for the first SKU to support a broader private label scalp-care line.  

    Frequently Asked Questions  

    Regulatory requirements and product classification depend on the final formula, device design, intended purpose, claims and target market. Final compliance should be reviewed for the specific commercial product before market launch.